Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • The Pharma 50

CRO Syneos Health hires new CEO

By Brian Buntz | April 29, 2022

Syneos HealthThe contract research organization (CRO) Syneos Health has promoted Michelle Keefe to be its CEO and a member of its board.

Keefe was previously the president, medical affairs and commercial solutions at Morrisville, North Carolina-based Syneos.

The company’s departing CEO, Alistair Macdonald, is retiring after working at the company for two decades.

Macdonald will serve as an advisor to the company until March 2023.

Michelle Keefe

Michelle Keefe

Keefe has more than three decades of experience working in the life sciences, including two decades at Pfizer.

“I am incredibly honored to take on this role and lead our talented colleagues around the globe,” Keefe wrote in a LinkedIn post. “I look forward to leveraging my decades of life sciences industry experience to help usher Syneos Health into its next chapter as a data- and insights-driven organization, addressing market opportunities with a product development mindset.”

In addition, Syneos has named Michael Brooks as its newly created chief operating officer role. Brooks was previously the company’s chief development officer and global head of clinical development solutions.

Syneos shares ticked up 4.18% to $73.41 in mid-day trading.


Filed Under: clinical trials, Drug Discovery, Drug Discovery and Development
Tagged With: contract research organization, CRO, Syneos Health
 

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Related Articles Read More >

Lab facility
Massachusetts is competing for ARPA-H biomedical research center
Blockchain
Startup vies to get blockchain adoption in pharma off the ground
Black Diamond Therapeutics
Black Diamond analysis highlights 22 new oncogenic HER2 driver mutations
NIH National Institutes of Health
NIH licenses COVID-19 research technologies to WHO initiative

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • The Pharma 50